RecruitingNot Applicable

Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder

Taiwan60 participantsStarted 2023-07-11

Plain-language summary

This research program is aimed to develop a integrative psychotherapy (including CBT and biofeedback therapy) and to examine its efficacy on treatment of somatic symptom disorder. The study design is a randomized controlled trial with waiting list control. Scores of Patient Health Questionniare-15 and Health Anxiety Questionnaire are the primary endpoints.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with somatic symptom disorder (confirmed by psychiatrists) Exclusion Criteria: * The age is younger than 20 or older than 70 years * Having psychotic symptoms or cognitive impairment * Having a potentially lethal illness * Cannot read the questionnaires by oneself

What they're measuring

Scores of Patient Health Questionnaire-15 (PHQ-15)

Timeframe: Week 12 (comparing with the data in week 0)

Scores of Health Anxiety Questionnaire (HAQ)

Timeframe: Week 12 (comparing with the data in week 0)

Trial details

NCT IDNCT05792930

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Wei-Lieh Huang, MD, PhD

886-5-5323911 weiliehhuang@gmail.com

View on ClinicalTrials.gov More Somatic Symptom Disorder trials